Skip to content

EPA library

Pediatric Hematology-Oncology

Royal College of Physicians and Surgeons of Canada · 1.0 · 26 EPAs

Also available in French.

Every EPA in the published guide, shown as the form DebriefMD fills in, with its fields and answer options.

Transition to Discipline

  • TTD-1

    Performing and presenting patient assessments relevant to Pediatric Hematology/Oncology

    Key features and assessment plan

    - This EPA applies the skills attained in Pediatrics related to clinical assessment and decision making to the care of patients with hematologic or oncologic conditions or presentations. - It includes synthesizing the clinical information as well as generating an appropriate differential diagnosis. - A plan for investigation or treatment may be proposed, but is not essential to the entrustment of this EPA. - This EPA requires direct observation of the resident performing the history and physical, as well as the case presentation; these segments may be observed individually, across multiple patients, or all together in one visit. - This EPA may be observed in any clinical setting, and during any type of patient visit.

    Direct observation of history and physical, and/or case presentation with supervisor (physician, senior trainee, or clinical associate) Use form 1. Form collects information on: - Segment observed (select all that apply): relevant history; physical exam; case presentation - Case: new patient; known patient Collect at least 2 observations of achievement. - At least 2 direct observations of history - At least 2 direct observations of physical exam - At least 2 case presentations - At least 1 new patient - At least 1 known patient - At least 1 observation by physician for each segment (history, physical exam, case presentation) - At least 2 observers

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Segment observed

    1. relevant history
    2. physical exam
    3. case presentation

    Case

    1. new patient
    2. known patient

    Medical Expert

    • ME 2.2 Elicit an accurate, relevant history
    • ME 2.2 Perform a physical examination that informs the diagnosis
    • ME 2.2 Develop a differential diagnosis
    • ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor

    Communicator

    • COM 2.1 Use patient-centred interviewing skills
    • COM 2.3 Seek and synthesize relevant information from other sources (e.g. family, medical record)

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • TTD-2

    Conveying information to patients and families regarding possible or probable diagnosis and the steps need…

    Key features and assessment plan

    - This EPA focuses on the application of the communication skills developed in pediatric residency. - This EPA may be observed with any patient presentation in which a malignant or significant hematologic diagnosis is likely.

    Direct observation by supervisor, with input from other health care professionals as available Use form 1. Collect 2 observations of achievement. - At least 2 different observers

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Communicator

    • COM 1.1 Develop trusting and supportive relationships with patients and families
    • COM 3.1 Provide accurate information about the medical condition and plans for investigation and/or management
    • COM 3.1 Use appropriate language and avoid medical jargon
    • COM 3.1 Use strategies to verify and validate the patient’s and/or family’s understanding
    • COM 1.5 Recognize when strong emotions (such as anger, fear, anxiety, or sadness) are impacting an interaction and respond appropriately
    • COM 4.3 Answer questions from the patient and/or family
    • COM 4.1 Communicate in a manner that is respectful, non-judgmental and culturally aware

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • TTD-3

    Obtaining consent and organizing for patients to receive transfusion or undergo diagnostic procedures

    Key features and assessment plan

    - This EPA focuses on the application of medical expertise and communication skills to convey the need, benefit and risk for, and alternatives to, common PHO therapies and procedures. - This includes the transfusion of any blood component/product, and the procedures of bone marrow aspiration/biopsy and lumbar puncture with or without intrathecal chemotherapy administration. - It includes optimizing the patient for the procedure and applying knowledge of local institutional protocols and policies to arrange for the transfusion or arrange the necessary logistics, services and/or resources in order to safely perform the procedure. - This EPA may be achieved in the simulation setting.

    Direct observation of consent and review of patient preparation by supervisor Use form 1. Form collects information on: - Segment observed (select all that apply): consent; patient preparation - Procedure (select all that apply): transfusion; lumbar puncture with intrathecal chemotherapy; bone marrow aspirate/biopsy Collect at least 3 observations of achievement. - At least 1 observation of consent for each procedure - At least 1 observation of patient preparation

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Segment observed

    1. consent
    2. patient preparation

    Procedure

    1. transfusion
    2. lumbar puncture with intrathecal chemotherapy
    3. bone marrow aspirate/biopsy

    Medical Expert

    • ME 1.3 Apply knowledge of the indications for and techniques and complications of common PHO therapies and procedures
    • ME 3.2 Explain the risks and benefits of and the rationale and alternatives for a proposed treatment or procedure
    • ME 2.2 Assess clinical status, peri-procedural risk and opportunities for risk mitigation
    • ME 3.4 Make arrangements for the treatment or procedure, applying knowledge of local policies and protocols
    • ME 3.4 Develop a plan for the appropriate disposition of the patient post procedure

    Communicator

    • COM 3.1 Use appropriate language and avoid medical jargon
    • COM 4.3 Answer questions from the patient and/or family
    • COM 5.1 Complete required documentation of a consent discussion

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

Foundations

  • F-1

    Providing consultation for patients with uncomplicated presentations of hematologic disorders, hematologic m…

    Key features and assessment plan

    - This EPA focuses on clinical assessment, including history, physical examination, and review of diagnostic tests, and synthesis of that information to provide a probable and differential diagnosis. - It also includes recommending additional investigations and/or referrals as needed, and documenting the consultation. - This EPA may be observed in any patient referred to hematology/oncology in a clinically stable condition. - Examples include: anemia, thrombocytopenia or leukopenia; lymphadenopathy, mediastinal mass or both; solid tumour; suspected intracranial mass; abnormal newborn screen; suspected bleeding disorder or thrombotic disorder.

    Case discussion and/or review of consult with supervisor Use form 1. Form collects information on: - Category: hematologic; oncologic - Presentation (write in): Collect 5 observations of achievement - At least 2 different hematology presentations - At least 2 different oncology presentations - At least 2 different observers

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Category

    1. hematologic
    2. oncologic

    Medical Expert

    • ME 2.2 Elicit a history relevant to the presentation
    • ME 2.2 Perform a physical examination that informs the diagnosis
    • ME 2.2 Select and/or interpret appropriate investigations
    • ME 2.2 Identify the clinical significance of diagnostic findings
    • ME 2.2 Develop a differential and most probable diagnosis
    • ME 2.2 Plan and coordinate a diagnostic workup

    Communicator

    • COM 5.1 Document a clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-2

    Explaining diagnoses and initial management plans to patients and families

    Key features and assessment plan

    - The focus of this EPA is the application of communication skills to clearly and compassionately convey the diagnosis and overview of management of a common malignancy or significant hematologic condition to patients and families. - This includes documenting the discussion.

    Direct observation and review of clinical documentation by supervisor, with input from other health care professionals as available Use form 1. Form collects information on: - Complexity: low; medium; high - Adolescent: yes; no - Diagnosis (write in): Collect 5 observations of achievement. - At least 1 adolescent - A variety of complexity and diagnoses - At least 2 different observers

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Complexity

    1. low
    2. medium
    3. high

    Adolescent

    1. yes
    2. no

    Medical Expert

    • ME 3.2 Describe a proposed therapy to the patient/family, including the rationale, possible toxicities, expected outcomes and alternative treatments

    Communicator

    • COM 1.1 Demonstrate empathy, respect and compassion
    • COM 3.1 Convey information about the diagnosis and plan for management clearly and accurately
    • COM 3.1 Use appropriate language and avoid medical jargon
    • COM 3.1 Use strategies to verify and validate the patient’s and/or family’s understanding
    • COM 1.5 Recognize when strong emotions (e.g. fear, anger, anxiety, sorrow) are impacting an interaction and respond appropriately
    • COM 1.5 Establish boundaries as needed in emotional situations
    • COM 4.3 Answer questions from the patient and/or family
    • COM 4.3 Use communication skills and strategies that help the patient and/or family make informed decisions
    • COM 4.1 Communicate in a manner that is respectful, non-judgmental and culturally aware
    • COM 5.1 Document the encounter to convey the discussion and its outcome

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-3

    Initiating treatment for patients with common, uncomplicated hematologic disorders, hematologic malignancies…

    Key features and assessment plan

    - This EPA focuses on the proposal of a therapeutic plan, based on the integration of clinical assessment and investigations to ascertain diagnosis, and if relevant, stage or severity of the underlying condition. - Examples include iron deficiency anemia, ITP, joint bleed in a patient with hemophilia, uncomplicated clot, sickle cell pain crisis, induction therapy for leukemia, and initial therapy for a solid tumour.

    Case discussion and review of clinical documentation by supervisor, senior trainee, clinical associate or nurse practitioner Use form 1. Form collects information on: - Category: hematologic; oncologic - Diagnosis (write in): Collect 5 observations of achievement. - At least 2 different hematologic - At least 2 different oncologic - At least 3 with supervising staff physician - At least 3 different observers

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Category

    1. hematologic
    2. oncologic

    Medical Expert

    • ME 2.2 Interpret the clinical data to establish the diagnosis and, if relevant, stage and/or severity of the condition
    • ME 2.4 Identify the role and availability of clinical trial participation as a therapeutic option
    • ME 2.4 Develop a management plan
    • ME 4.1 Establish a plan for follow-up on investigations and response to treatment

    Communicator

    • COM 5.1 Document the encounter to convey the discussion and its outcome

    Health Advocate

    • HA 1.1 Identify barriers to access and care for individual patients

    Professional

    • P 1.2 Demonstrate awareness of the limits of one’s expertise, and seek assistance as needed

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-4

    Prescribing systemic therapies, including intrathecal therapy

    Key features and assessment plan

    - This EPA focuses on safely ordering conventional cytotoxic therapy, demonstrating knowledge of pharmacology and expected adverse events and their prevention/ management. - This includes assessing the need to modify dose and/or delay treatment, ordering appropriate monitoring strategies, and incorporating appropriate supportive care. - It also includes working effectively with the interprofessional team, i.e. pharmacists, nurses, and following standard operating procedures in the ordering and administration of systemic therapy. - The observation of this EPA should include some regimens of high complexity: highly complex orders include those that require hydration and/or anti-nauseants or other supportive care, and those that need significant adjustments for patient factors.

    Case discussion and review of orders by supervising physician, nurse practitioner or pharmacist Use form 1. Form collects information on: - Diagnosis (write in): - Complexity of regimen: low; medium; high Collect 8 observations of achievement - At least 3 different diagnoses - At least 5 high complexity regimens - At least 3 observations by supervising physician

    Suggested observations: 8

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.3 Apply knowledge of conventional cytotoxic chemotherapy, including pharmacology, expected adverse events and their prevention/management
    • ME 2.2 Assess a patient’s suitability to proceed with systemic therapy
    • ME 2.4 Select and prescribe the appropriate dose and regimen
    • ME 2.4 Modify or adjust the dose and/or timing of therapy as needed
    • ME 2.4 Select and prescribe appropriate monitoring strategies
    • ME 2.4 Select and prescribe supportive care to optimize patient comfort and mitigate adverse effects
    • ME 5.2 Follow standard operating procedures when ordering and/or administering systemic therapy

    Collaborator

    • COL 1.2 Work effectively with pharmacists and nurses

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-5

    Performing the procedures of Pediatric Hematology/Oncology

    Key features and assessment plan

    - This EPA focuses on the performance of bone marrow aspiration, bone marrow biopsy, and lumbar puncture with or without intrathecal chemotherapy, in pediatric patients of any age, body size or habitus. - This includes confirming that consent has been obtained, preparing materials, safe handling of instruments, biologic samples and biohazardous material, performing the procedure, obtaining an adequate sample (determined by visual assessment at the time of the procedure) and managing any immediate procedure related complications. - It also includes verification and documentation of chemotherapy administration, as relevant.

    Direct observation by supervisor (physician, senior resident, nurse practitioner or clinical associate) Use form 1. Form collects information on: - Patient age (write in): - Perceived difficulty: typical; challenging - Procedure (select all that apply): lumbar puncture; intrathecal chemo; bone marrow aspirate; bone marrow biopsy Collect at least 8 observations of achievement. - At least 4 lumbar punctures with intrathecal chemo - At least 4 bone marrow aspirates - At least 4 bone marrow biopsies - At least 2 adolescents with lumbar puncture

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 3.1 Determine the safety and appropriateness of the procedure
    • ME 3.2 Obtain and document informed consent, explaining the risks and rationale for a proposed procedure
    • ME 3.4 Demonstrate effective procedure preparation, including patient identification and/or safety checklist as appropriate
    • ME 3.4 Prepare to obtain and handle samples, sending for appropriate testing
    • ME 3.4 Set up and position the patient for the procedure
    • ME 3.4 Maintain universal precautions
    • ME 3.4 Prepare and cleanse the procedural site
    • ME 3.4 Perform a procedure in a skilful and safe manner, adapting to unanticipated findings or changing clinical circumstances
    • ME 3.4 Verify and administer intrathecal medication
    • ME 3.4 Demonstrate safe handling of instruments, biologic samples and/or biohazardous material
    • ME 3.4 Recognize and manage complications
    • ME 3.4 Document the procedure, including adequacy of specimen obtained and the presence/absence of complications

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-6

    Recognizing and interpreting the clinical significance of critical findings of morphology studies

    Key features and assessment plan

    - This EPA focuses on applying knowledge of hematopathology laboratory tests and procedures to interpret CBC and peripheral blood and fluid morphology, and recognize critical findings that affect clinical decisions in an urgent manner. - Examples include blasts in the peripheral smear or CSF in suspected leukemia, thrombotic microangiopathy and first time detection of sickle cells. - This EPA does not include providing the official report of hematopathology findings.

    Direct observation or case discussion by supervising physician, laboratory physician or laboratory technologist Use form 1. Form collects information on: - Setting: laboratory; clinical service - Classification: benign; malignant; other laboratory finding (please specify) - Diagnosis (write in): Collect 3 observations of achievement. - A variety of diagnoses - At least 2 different observers

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Setting

    1. laboratory
    2. clinical service

    Classification

    1. benign
    2. malignant
    3. other laboratory finding (please specify)

    Medical Expert

    • ME 1.3 Apply knowledge of peripheral blood morphology
    • ME 1.3 Apply knowledge of cerebrospinal fluid assessment
    • ME 2.2 Perform a morphologic assessment and recognize critical findings
    • ME 2.2 Establish a diagnosis that takes into account clinical correlation
    • ME 2.4 Provide suggestions for further testing and/or management as relevant

    Communicator

    • COM 5.1 Communicate critical results urgently, as needed

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

Core

  • C-1

    Developing and implementing treatment plans for patients with pediatric hematology and oncology conditions

    Key features and assessment plan

    - This EPA focuses on the definitive management of Pediatric Hematology/Oncology conditions. - This includes synthesizing clinical assessments and investigations to reach a diagnosis and developing a plan of care for comprehensive management that considers the unique aspects of each patient’s condition, co-morbidities, age, development, presentation and goals of care. - This may include eligibility for clinical trials, and may require scholarly review of treatment options and/or multidisciplinary collaboration or consultation with external experts. - This EPA may be observed in any clinical setting and with any hematologic disease or any cancer. - The case mix in the resident’s portfolio should include the full spectrum of clinical classification, treatment phase, treatment modality, and patient setting to reflect the diversity found within the specialty.

    Direct observation, case discussion or chart review by supervising physician Use form 1. Form collects information on: - Complexity: low; medium; high - Category: hematologic; oncologic - Diagnosis (write in): - HSCT or cellular therapy considered: not applicable; no; yes-auto; yes-allo Collect 12 observations of achievement. - At least 4 hematologic conditions - At least 4 oncologic conditions - At least 2 include HSCT or cellular therapy in the treatment plan - At least 1 includes allogenic HSCT - At least 3 different observers

    Suggested observations: 12

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Complexity

    1. low
    2. medium
    3. high

    Category

    1. hematologic
    2. oncologic

    Medical Expert

    • ME 1.3 Apply knowledge of the clinical and biomedical sciences relevant to Pediatric Hematology/ Oncology
    • ME 1.4 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Integrate the clinical data to establish the diagnosis and, if relevant, stage and/or severity of the condition
    • ME 2.3 Establish goals of care in collaboration with patients and their families
    • ME 2.4 Identify the role and availability of clinical trials participation as a therapeutic option
    • ME 2.2 Identify whether the case warrants discussion at multidisciplinary case conference
    • ME 2.4 Develop a management plan
    • ME 4.1 Determine the need and timing of referral to another physician
    • ME 4.1 Coordinate treatment and follow-up plans

    Communicator

    • COM 3.1 Share information about the patient’s condition and plans for management clearly and compassionately

    Collaborator

    • COL 1.2 Work effectively with members of the interprofessional team to implement a management plan

    Leader

    • L 2.1 Consider costs and resource availability when selecting diagnostic or treatment options

    Scholar

    • S 3.4 Perform a scholarly review of available treatment options
    • S 3.4 Apply an evidence-based approach to clinical management

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-2

    Leading discussions with patients, families and/or other health care professionals in emotionally charged si…

    Key features and assessment plan

    - This EPA focuses on the application of advanced communication and conflict resolution skills to address difficult situations that involve patients, families, and/or members of the health care team. - This EPA may be observed in any scenario that is emotionally charged. Examples include: disclosing an adverse event; cancer relapse or failure of therapy; difference of opinion with another care provider; dealing with a patient complaint; request for an autopsy; referral to child protection services.

    Direct observation by supervisor, with input from others involved in the interaction Use form 1. Form collects information on: - Setting: clinical; simulation - Scenario (write in): Collect 3 observations of achievement. - No more than 1 in simulation setting - At least 2 different observers

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Setting

    1. clinical
    2. simulation

    Medical Expert

    • ME 2.1 Ascertain participants’ understanding of the situation and the reason for the encounter

    Communicator

    • COM 1.1 Demonstrate empathy, respect and compassion
    • COM 3.1 Share information and explanations that are clear and accurate
    • COM 3.1 Verify understanding of the information conveyed
    • COM 1.4 Identify, verify and validate non-verbal cues
    • COM 4.3 Answer questions in a respectful manner
    • COM 1.6 Assess how each patient’s personal story impacts their unique needs and preferences
    • COM 2.2 Manage the flow of the encounter
    • COM 1.5 Recognize when strong emotions (such as anger, fear, anxiety, or sadness) are impacting an interaction and respond appropriately
    • COM 1.5 Establish boundaries as needed in emotional situations
    • COM 2.2 Summarize and close the encounter effectively
    • COM 5.1 Document the encounter to convey the discussion and its outcome

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-3

    Providing ongoing management for patients with chronic hematologic disorders

    Key features and assessment plan

    - This EPA focuses on providing ongoing comprehensive management that includes implementing screening, surveillance, or monitoring strategies, assessing medication adherence and effects, as well as addressing patient concerns, education and appropriate follow up. - It includes identifying patients with a fluctuating clinical course, recognizing the need for change or escalation of therapy, and implementing a therapeutic plan. - This EPA must be observed in a range of conditions. Examples include hemoglobinopathies, bleeding disorders, thrombophilias, and marrow failures.

    Case review and/or review of clinical documentation by supervisor (staff physician or TTPractice resident) Use form 1. Form collects information on: - Diagnosis: sickle cell disease; other hemoglobinopathy; hemophilia; thalassemia; chronic ITP; thrombosis; marrow failure syndrome; immune dysregulation; other diagnosis - Issue (select all that apply): stable condition; progressive condition; initiate and/or change therapy; manage complications; arrange/review surveillance; supportive/preventive care; counsel/educate; other issue Collect 8 observations of achievement. - A mix of diagnoses - A mix of issues - At least 2 different observers

    Suggested observations: 8

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Diagnosis

    1. sickle cell disease
    2. other hemoglobinopathy
    3. hemophilia
    4. thalassemia
    5. chronic ITP
    6. thrombosis
    7. marrow failure syndrome
    8. immune dysregulation
    9. other diagnosis

    Issue

    1. stable condition
    2. progressive condition
    3. initiate and/or change therapy
    4. manage complications
    5. arrange/review surveillance
    6. supportive/preventive care
    7. counsel/educate
    8. other issue

    Medical Expert

    • ME 1.4 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Assess the impact of the medical condition on the patient’s growth, development and ability to pursue life goals
    • ME 2.2 Interpret the results of investigations performed to monitor the condition and/or treatment
    • ME 2.2 Synthesize patient information to determine clinical status, response to treatment and/or toxicity
    • ME 2.3 Integrate the patient’s and family’s perspective and context into the care plan
    • ME 2.4 Develop a plan for management, which may include modification of current therapy
    • ME 4.1 Determine the need and timing of referral to another physician
    • ME 4.1 Determine the frequency and timing of future investigations and visits

    Communicator

    • COM 4.2 Facilitate self-care and chronic disease management
    • COM 4.3 Use communication skills and strategies that help the patient and/or family make informed decisions
    • COM 5.1 Document a clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations

    Collaborator

    • COL 3.1 Determine when care should be transferred back to a primary care provider

    Leader

    • L 2.1 Consider costs and resource availability when selecting diagnostic or treatment options

    Health Advocate

    • HA 1.3 Incorporate prevention, health promotion and health surveillance into patient interactions

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-4

    Providing ongoing management for patients receiving cancer therapy

    Key features and assessment plan

    - This EPA focuses on providing ongoing care for patients receiving cancer therapy for a variety of underlying conditions. - It includes surveillance for treatment efficacy, complications and side effects, providing supportive care, recognizing the need for change or escalation of therapy and implementing a therapeutic plan.

    Case review and/or review of clinical documentation by supervisor (staff physician or TTPractice resident) Use form 1. Form collects information on: - Diagnosis (write in): - Treatment plan (select all that apply): dose modification; modification of supportive care; assess response to therapy; other treatment Collect 6 observations of achievement. - A mix of leukemia and solid tumours - A mix of treatment plans - At least 3 different observers

    Suggested observations: 6

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.4 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Interpret the results of investigations performed to monitor the condition and/or treatment
    • ME 2.2 Differentiate signs and symptoms of disease and/or disease progression from adverse effects of treatment
    • ME 2.2 Synthesize patient information to determine clinical status, response to treatment and/or toxicity
    • ME 2.3 Integrate the patient’s and family’s perspective and context into the care plan
    • ME 2.4 Develop a plan for management, which may include modification of current therapy
    • ME 4.1 Determine the need and timing of referral to another physician
    • ME 4.1 Coordinate treatment and follow-up plans

    Communicator

    • COM 4.3 Use communication skills and strategies that help the patient and/or family make informed decisions
    • COM 5.1 Document a clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-5

    Assessing patients who have received HSCT or cellular therapy, recognizing complications, and administering …

    Key features and assessment plan

    - This EPA focuses on the follow-up care provided for patients following HSCT or cellular therapy: screening for and recognizing complications in order to make a diagnosis and consult effectively with the HSCT team. - This requires knowledge of the toxicities specific to HSCT or cellular therapies. - This EPA includes recognition and investigation of conditions and may include initiation of urgent therapies; however treatment decisions would often be made in conjunction with the HSCT specialist. - This EPA may include acute, late acute and chronic (e.g. GVHD) complications, as well as graft failure and late effects. - Direct observation of a physical examination for assessment of GVHD is required on at least one occasion.

    Direct observation and/or case review by supervisor Use form 1. Form collects information on: - Observed physical exam: yes; no - Complication (select all that apply): none; acute GVHD; chronic GVHD; SOS; transplant associated microangiopathy; graft failure/mixed chimerism; cytokine release syndrome; other complication Collect 3 observations of achievement. - At least 1 observed physical exam for chronic GVHD - At least 1 patient with acute GVHD

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Observed physical exam

    1. yes
    2. no

    Complication

    1. none
    2. acute GVHD
    3. chronic GVHD
    4. SOS
    5. transplant associated microangiopathy
    6. graft failure/mixed chimerism
    7. cytokine release syndrome
    8. other complication

    Medical Expert

    • ME 1.3 Apply knowledge of HSCT and cellular therapy, and their toxicities and complications
    • ME 1.4 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Perform a physical exam to detect evidence of GVHD
    • ME 2.2 Select and/or interpret appropriate investigations
    • ME 2.2 Synthesize patient information to determine diagnosis
    • ME 2.4 Develop and implement a plan for initial management
    • ME 2.4 Incorporate consultant recommendations to develop and implement a definitive management plan
    • ME 4.1 Establish a plan for follow-up on investigations and response to treatment

    Communicator

    • COM 3.1 Provide timely, accurate information and explanations to the patient and/or family

    Collaborator

    • COL 1.3 Communicate effectively with the HSCT team

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-6

    Preparing patients for HSCT or cellular therapy

    Key features and assessment plan

    - This EPA includes reviewing the indications for HSCT or cellular therapy, describing the treatment and its short and long term risks, completing appropriate investigations and identifying the appropriate timing and urgency of referral.

    Direct observation or case review by supervising physician Use form 1: Form collects information on: - Type of referral: HSCT – allogeneic; HSCT – autologous; cellular therapy Collect 1 observation of achievement.

    Suggested observations: 1

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Type of referral

    1. HSCT – allogeneic
    2. HSCT – autologous
    3. cellular therapy

    Medical Expert

    • ME 1.4 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Recognize when a patient may benefit from referral for HSCT or cellular therapy
    • ME 2.2 Identify whether the case warrants discussion at multidisciplinary case conference
    • ME 4.1 Determine the need and timing of referral to another physician
    • ME 3.2 Describe a proposed therapy to the patient/family, including the rationale, possible toxicities, expected outcomes and alternative treatments
    • ME 2.2 Plan and coordinate an appropriate diagnostic workup
    • ME 4.1 Formulate clear and complete requests for consultation

    Communicator

    • COM 3.1 Convey information about the treatment options clearly and accurately
    • COM 4.3 Use communication skills and strategies that help the patient and/or family make informed decisions

    Collaborator

    • COL 3.2 Organize the handover of care to the most appropriate physician

    Health Advocate

    • HA 1.1 Identify barriers to access and care for individual patients
    • HA 1.1 Facilitate timely patient access to services and resources

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-7

    Participating in the accrual of patients to clinical trials

    Key features and assessment plan

    - This EPA highlights the central role of clinical trials in the care of patients with pediatric hematologic disease or cancer. - It includes identifying opportunities to participate in clinical trials and enrolling patients, with a focus on the discussion with patients and families that explains the study and presents information required for a decision regarding consent for trial participation. - This EPA may be observed with any clinical trial.

    Direct observation and review of consent documentation by supervisor Use form 1. Form collects information on: - Diagnosis (write in): - Type of study: therapeutic; other type of study Collect 3 observations of achievement. - At least 1 therapeutic oncology trial - At least 2 different diagnoses - At least 2 different observers

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 2.4 Identify the role and availability of clinical trial participation as a therapeutic option
    • ME 3.2 Describe a proposed therapy to the patient/family, including the rationale, possible toxicities, expected outcomes and alternative treatments
    • ME 2.4 Discuss the degree of uncertainty inherent to the clinical situation

    Communicator

    • COM 3.1 Convey information about the treatment options clearly and accurately
    • COM 3.1 Use appropriate language and avoid medical jargon
    • COM 3.1 Verify understanding of the information conveyed
    • COM 5.1 Document the consent discussion in a manner compliant with GCP standards

    Scholar

    • S 4.2 Incorporate ethical principles of research in discussions regarding enrollment for a clinical trial
    • S 4.2 Advise regarding the right not to participate
    • S 4.3 Balance the roles and responsibilities of a researcher with the clinical roles and responsibilities of a physician

    Professional

    • P 3.1 Adhere to professional and ethical codes of practice

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-8

    Providing consultation and advice to off-site health care providers and patients

    Key features and assessment plan

    - This EPA focuses on providing appropriate and timely advice about management and/or patient disposition as well as recognizing conditions that can be managed remotely (by telephone) versus those that require in-person assessment. - This EPA includes responding to calls from patients as well as physicians/surgeons and other health care professionals.

    Direct observation or case review with supervisor, which may include feedback from the person initiating the call Use form 1. Form collects information on: - Caller: patient/family; physician - Decision: nil to do; manage at home; admit/ER; refer not urgent; other decision - Issue (write in): Collect 3 observations. - At least 1 patient/family - At least 1 physician - At least 1 patient brought in to hospital - At least 1 patient managed at home/community

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Caller

    1. patient/family
    2. physician

    Decision

    1. nil to do
    2. manage at home
    3. admit/ER
    4. refer not urgent
    5. other decision

    Medical Expert

    • ME 2.2 Interpret the clinical data to establish the diagnosis and, if relevant, stage and/or severity of the condition
    • ME 2.4 Determine the setting of care appropriate for the patient’s health needs
    • ME 4.1 Provide recommendations for additional investigations and/or next steps in management and treatment

    Communicator

    • COM 2.3 Gather patient information from a family member or health care professional
    • COM 5.1 Document advice provided by telephone to patients or other health care providers

    Collaborator

    • COL 3.1 Determine when a patient should be transferred to ensure optimal patient care
    • COL 3.2 Recognize and act on patient safety issues in the transfer of care
    • COL 1.3 Work effectively with other physicians and health care professionals

    Leader

    • L 2.1 Apply knowledge of the health care resources available in other care settings

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-9

    Providing management for patients with emergencies related to hematologic or oncologic conditions or their t…

    Key features and assessment plan

    - This EPA focuses on the skills of providing or arranging for definitive management for a spectrum of hematologic/oncologic emergencies and treatment-related emergencies. - Examples include: unstable fever and neutropenia; high risk of tumour lysis syndrome; symptomatic mediastinal mass; sickle cell acute complications (e.g. stroke, splenic sequestration, severe acute chest syndrome); life or organ function- threatening thrombosis; hyperleukocytosis; spinal cord compression; intracranial hemorrhage; sepsis; DIC; increased ICP; severe transfusion reactions; allergic reactions to medications; and cytokine release syndrome.

    Direct observation or case review by supervising physician, nurse practitioner, or clinical assistant Use form 1. Form collects information on: - Setting: inpatient; outpatient; emergency department; simulation; other setting - Diagnosis (write in): Collect 4 observations of achievement. - At least 3 different clinical diagnoses - At least 2 hematologic emergencies - At least 2 oncologic emergencies

    Suggested observations: 4

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Setting

    1. inpatient
    2. outpatient
    3. emergency department
    4. simulation
    5. other setting

    Medical Expert

    • ME 2.1 Recognize instability and medical acuity in a clinical presentation
    • ME 2.1 Determine the acuity of the issue and the priorities for patient care
    • ME 2.2 Perform a history and physical exam relevant to the patient presentation, in a time- effective manner
    • ME 2.2 Select and/or interpret appropriate investigations
    • ME 2.2 Develop a differential diagnosis
    • ME 2.4 Apply emergency care protocols for emergencies related to hematologic or oncologic conditions or their treatment
    • ME 4.1 Determine appropriate disposition and/or setting for ongoing care

    Communicator

    • COM 3.1 Share information about the patient’s condition and plans for management clearly and compassionately
    • COM 5.1 Document the encounter to convey the outcome and rationale for clinical decisions

    Collaborator

    • COL 1.1 Receive and appropriately respond to input from other members of the team

    Professional

    • P 4.1 Maintain capacity for professional clinical performance in stressful situations

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-10

    Developing and implementing a survivorship surveillance plan for patients who have completed cancer treatment

    Key features and assessment plan

    - This EPA focuses on the development of a plan for ongoing monitoring and management that incorporates risk of disease recurrence/ relapse, risk of possible long term adverse effects, and risk of second malignancies, as well as ongoing supportive care and optimization of health, growth and development. - This EPA may be observed for any patient with a cancer diagnosis.

    Review of written surveillance plan by supervisor Use form 1. Form collects information on: - Diagnosis (write in): - Case complexity: medium; high Collect 2 observations of achievement. - At least 2 different diagnoses - At least 1 of high complexity

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.3 Apply knowledge of the natural history of cancer
    • ME 1.3 Apply knowledge of the late effects of therapy
    • ME 2.2 Assess a patient’s risk of cancer relapse/recurrence and potential late effects of therapy
    • ME 2.2 Assess the impact of the medical condition on the patient’s growth, development and ability to pursue life goals
    • ME 2.2 Interpret the results of investigations performed to monitor the condition and/or its treatment
    • ME 4.1 Determine the frequency and timing of future investigations and visits

    Collaborator

    • COL 3.1 Determine when care should be transferred back to a primary care provider
    • COL 1.3 Provide timely pertinent information to other health care providers

    Health Advocate

    • HA 1.3 Counsel patients regarding relevant preventive health care
    • HA 1.2 Work with patients to increase opportunities for self-care and independence
    • HA 1.2 Work with patients to facilitate reintegration into school and/or work

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-11

    Providing care for patients at end of life

    Key features and assessment plan

    - This EPA focuses on patients whose goals of care are transitioning to an emphasis on quality of life rather than disease modification or cure. - This includes establishing goals of care, providing care appropriate to those goals, and managing disabling symptoms. - It also includes providing anticipatory guidance for the patient and family, providing support to the family and facilitating access to resources for ongoing care. - This EPA may be observed in any setting, and in patients with any condition.

    Direct observation and/or case review by supervisor Use form 1. Collect 1 observation of achievement.

    Suggested observations: 1

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 2.3 Work with the patient and family to establish goals of care
    • ME 2.2 Identify symptoms influencing patient comfort at the end of life
    • ME 2.2 Determine symptom management priorities
    • ME 2.4 Develop palliative care management plans that align with patient and family goals of care
    • ME 2.3 Share concerns about goals that may not be achievable and initiate discussion about addressing these concerns

    Communicator

    • COM 1.1 Develop trusting and supportive relationships with families in distress
    • COM 3.1 Provide information related to progression of illness and evolution of care
    • COM 3.1 Educate patients and families about end of life care options
    • COM 5.1 Document the encounter to convey the discussion and its outcome

    Collaborator

    • COL 1.3 Consult with other health care professionals as is appropriate for optimal patient care

    Health Advocate

    • HA 1.1 Facilitate access to community care resources
    • HA 1.1 Facilitate access to bereavement support for a patient’s family, as appropriate

    Professional

    • P 1.3 Recognize and respond to the moral and ethical challenges in end of life care
    • P 4.1 Exhibit self-awareness, recognizing and managing the impact of end of life care on personal well-being and professional performance

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-12

    Planning and implementing transfers of care for patients transitioning to another setting and/or stage of care

    Key features and assessment plan

    - The focus of this EPA is the transfer of professional responsibility for patient care. - Examples include transition from pediatric to adult care; from acute care to survivorship care; from specialty care to a primary care provider. - This EPA does not include transfers that occur within an acute care hospital admission (i.e. ward to ICU). - This EPA includes synthesis of the patient’s care journey, and anticipation of ongoing care needs, potential late effects and/or risks, and any plan for ongoing screening of both medical and psychosocial needs. - This EPA may be observed with any hematology or oncology patient.

    Review of written transfer of care plan by supervisor Use form 1. Form collects information on: - Case complexity: medium; high - Setting: longitudinal clinic (continuity of care); transitional clinic (from pediatrics to adult care); patient moving jurisdiction; referral back to primary care; transfer to survivorship care Collect 2 observations of achievement. - At least 2 complex patients - At least 1 transition from pediatric to adult care

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Case complexity

    1. medium
    2. high

    Setting

    1. longitudinal clinic (continuity of care)
    2. transitional clinic (from pediatrics to adult care)
    3. patient moving jurisdiction
    4. referral back to primary care
    5. transfer to survivorship care

    Medical Expert

    • ME 1.3 Apply knowledge of the natural history of conditions relevant to Pediatric Hematology/Oncology
    • ME 2.2 Assess the indications and timing of transition to another setting and/or stage of care
    • ME 2.4 Determine the setting of care appropriate for the patient’s health needs
    • ME 4.1 Establish plans for ongoing care that include monitoring health status and anticipate the progression of the patient’s condition

    Collaborator

    • COL 1.3 Incorporate information and the perspectives of other members of the health care team when developing a plan for transition
    • COL 3.2 Summarize all relevant issues of the clinical case in a transfer summary
    • COL 3.2 Provide guidance for management of ongoing issues as well as anticipated changes in the clinical course

    Leader

    • L 2.1 Apply knowledge of the health care resources available in other care settings

    Health Advocate

    • HA 1.1 Facilitate timely patient access to services and resources

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-13

    Managing longitudinal aspects of care

    Key features and assessment plan

    - This EPA focuses on the longitudinal management of a group of patients in the role of the physician most responsible for patient care, i.e. in a continuity clinic. - This includes responsibility for medical care decisions and follow-up on investigations, providing all relevant aspects of care at and between patient visits, and working effectively with the other health care professionals. - It also includes appropriate accessibility in between clinic visits and arranging for coverage by another physician while away. - The observation of this EPA is not based on a single patient encounter, but rather on the resident performance over a period of time.

    Direct and indirect observation by supervisor(s), with input from other faculty members, nurse, clerk +/- other health care professionals Use form 3. Collect at least 2 observations at 3-6 month intervals.

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.1 Demonstrate responsibility and accountability for decisions regarding patient care, acting in the role of most responsible physician
    • ME 2.4 Develop and implement management plans that anticipate progress in/changes through the clinical course

    Collaborator

    • COL 1.3 Work effectively with other physicians and health care professionals

    Leader

    • L 4.1 Review and act on test results in a timely manner
    • L 4.1 Manage time effectively in the outpatient clinic

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Professional

    • P 1.2 Demonstrate awareness of the limits of one’s expertise, and seek assistance as needed
    • P 1.1 Respond punctually to requests from patients or other health care professionals
    • P 1.1 Make arrangements for coverage by another physician when absent or unavailable

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-14

    Leading the team providing patient care on the PHO ward or service

    Key features and assessment plan

    - This EPA includes all aspects of leading an inpatient team, including responsibility for the medical care decisions, collaboration with other health care professionals, and communication with patients and families. - The observation of this EPA is based on a week of clinical activity.

    Direct and indirect observation by supervisor, with input from other members of the interprofessional team Use form 1. Form collects information on: - Complexity/volume of case load: low; average; high - Input collected from (select all that apply): nurse; other health care professional; junior resident/student Collect 2 observations of achievement. - At least 1 case load of high complexity - Input from at least 2 different members of the health care team - At least 2 different weeks and 2 different supervisors

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Complexity/volume of case load

    1. low
    2. average
    3. high

    Input collected from

    1. nurse
    2. other health care professional
    3. junior resident/student

    Medical Expert

    • ME 3.1 Determine the most appropriate procedures or therapies for the purpose of assessment and/or management
    • ME 2.4 Develop and implement plans for ongoing care, discharge, and follow-up

    Communicator

    • COM 3.1 Share information about the medical course and plans with patients and families

    Collaborator

    • COL 1.2 Delegate responsibilities to members of the health care team appropriate to their scope of practice and level of expertise
    • COL 1.3 Work effectively with other physicians and health care professionals

    Leader

    • L 4.1 Manage time and prioritize tasks
    • L 2.1 Allocate health care resources for optimal patient care

    Health Advocate

    • HA 1.1 Facilitate timely patient access to services and resources

    Scholar

    • S 3.4 Apply an evidence-based approach to clinical management
    • S 2.4 Provide teaching for junior learners
    • S 2.5 Provide junior learners with feedback to enhance learning and performance

    Professional

    • P 1.1 Exhibit appropriate professional behaviors

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-15

    Delivering scholarly teaching to a variety of audiences, including peers, junior trainees and/or other heal…

    Key features and assessment plan

    - This EPA focuses on the skills of critical appraisal as well as presentation and teaching skills. - This EPA may be observed in a variety of settings. Examples include grand rounds or divisional rounds, lectures to students or other residents, educational sessions for patients and families, journal club presentations, and protocol rounds.

    Direct observation by supervisor, incorporating feedback from audience members Use form 1. Form collects information on: - Type of activity: journal club; grand or divisional rounds; academic half day; other activity Collect 2 observations of achievement.

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Type of activity

    1. journal club
    2. grand or divisional rounds
    3. academic half day
    4. other activity

    Scholar

    • S 2.4 Identify the learning needs and desired learning outcomes of others
    • S 2.4 Develop learning objectives for a teaching activity
    • S 3.3 Critically evaluate the integrity, reliability and applicability of health-related research and literature
    • S 3.4 Integrate best evidence and clinical expertise
    • S 2.4 Present the information in an organized manner to facilitate understanding
    • S 2.4 Use audiovisual aids effectively
    • S 2.4 Provide adequate time for questions and discussion

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

Transition to Practice

  • TTP-1

    Running a Pediatric Hematology/Oncology practice amidst other responsibilities

    Key features and assessment plan

    - This EPA focuses on managing the caseload of a staff physician: providing quality care for individual patients, triaging and prioritizing between patients and amongst patients and other occupational demands, fulfilling those other responsibilities, and demonstrating judicious use of resources. - The observation of this EPA is based on a block of time of at least a week during which the resident has inpatient and/or outpatient responsibilities.

    Direct and/or indirect observation by supervisor based on a block of time (e.g. week, block of service), with input from other health care professionals Use form 1. Form collects information on: - Setting (select all that apply): inpatient; outpatient; hematology; oncology - Includes input from (select all that apply): clinical associate; nurse practitioner; physician assistant; charge nurse; other nurse; social worker; other resident; medical student(s); clerical staff; other health care professional Collect 2 observations of achievement. - At least 1 with inpatient focus - At least 1 with outpatient focus - Balance of hematology and oncology settings - At least 2 different attending physicians

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Setting

    1. inpatient
    2. outpatient
    3. hematology
    4. oncology

    Includes input from

    1. clinical associate
    2. nurse practitioner
    3. physician assistant
    4. charge nurse
    5. other nurse
    6. social worker
    7. other resident
    8. medical student(s)
    9. clerical staff
    10. other health care professional

    Medical Expert

    • ME 1.1 Demonstrate responsibility and accountability for decisions regarding patient care, acting in the role of most responsible physician
    • ME 1.5 Prioritize patients based on the urgency of clinical presentations
    • ME 2.4 Establish patient- and family-centred management plans

    Leader

    • L 4.1 Set priorities and manage time to fulfil diverse responsibilities
    • L 2.1 Allocate health care resources for optimal patient care
    • L 4.1 Integrate supervisory and teaching responsibilities into the overall management of the clinical service

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Professional

    • P 4.1 Manage the mental and physical challenges that impact physician wellness and/or performance in demanding or stressful clinical settings

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • TTP-2

    Facilitating access to treatments and/or services for individual patients

    Key features and assessment plan

    - This EPA focuses on facilitating timely access to pharmacological and non- pharmacological treatments, and/or financial, psychological, or social support. - This may include special authorizations, disability applications, access to out of country testing, and access to special tests or therapies. - This EPA may require scholarly investigation to support the request for medication/ testing/ intervention. - This EPA can be observed using a simulated case or issue.

    Review of completed documents (forms or letters) by supervisor Use form 1. Form collects information on: - Request type: special authorization for meds; special authorization for testing; disability/insurance; other Collect 2 observations of achievement. - At least 1 special authorization for meds or testing

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Request type

    1. special authorization for meds
    2. special authorization for testing
    3. disability/insurance
    4. other

    Communicator

    • COM 5.1 Complete third party clinical documentation in a thorough, responsible and timely manner

    Health Advocate

    • HA 1.1 Facilitate timely patient access to services and resources
    • HA 1.1 Apply the criteria for authorization of treatments, testing or other special interventions

    Scholar

    • S 3.3 Perform a literature search to address a clinical question
    • S 3.3 Critically evaluate the integrity, reliability, and applicability of health-related research and literature
    • S 4.5 Summarize the findings of a literature review

    Case description

    Feedback provided

    Next steps

    Copyright © 2020 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.